Quantifying HTLV-I dynamics (Q36764476)

16 August 2017

1 reference

title

Quantifying HTLV-I dynamics (English)

1 reference

Human T-lymphotropic virus 1

16 August 2017

0 references

Becca Asquith

1

0 references

author name string

Charles R M Bangham

series ordinal

2

1 reference

16 August 2017

20 March 2007

1 reference

Immunology & Cell Biology

16 August 2017

1 reference

16 August 2017

85

1 reference

16 August 2017

280-286

1 reference

16 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.icb.7100050

16 August 2017

0 references

cites work

Long-term variations in human T lymphotropic virus (HTLV)-I and HTLV-II proviral loads and association with clinical data

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Fluctuation of HTLV-I proviral DNA in peripheral blood mononuclear cells of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Clinical investigation of pulmonary Mycobacterium avium complex infection in human T lymphotrophic virus type I carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

In vivo analysis of human T-cell leukemia virus type 1 reverse transcription accuracy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Molecular evolution of human T-cell leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

HTLV-I specific IFN-gamma+ CD8+ lymphocytes correlate with the proviral load in peripheral blood of infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Cytotoxic T-cell abundance and virus load in human immunodeficiency virus type 1 and human T-cell leukaemia virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Analysis of 'driver' and 'passenger' CD8+ T-cell responses against variable viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Increased HTLV type 1 tax specific CD8+ cells in HTLV type 1-asociated myelopathy/tropical spastic paraparesis: correlation with HTLV type 1 proviral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Population dynamics of immune responses to persistent viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

A functional CD8+ cell assay reveals individual variation in CD8+ cell antiviral efficacy and explains differences in human T-lymphotropic virus type 1 proviral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Measurement and modeling of human T cell kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Cytotoxic T lymphocytes and viral turnover in HIV type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

A novel antiviral intervention results in more accurate assessment of human immunodeficiency virus type 1 replication dynamics and T-cell decay in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Viral dynamics in human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Reversion of immune escape HIV variants upon transmission: insights into effective viral immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Inefficient cytotoxic T lymphocyte-mediated killing of HIV-1-infected cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

HIV replication elicits little cytopathic effects in vivo: analysis of surrogate markers for virus production, cytotoxic T cell response and infected cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

The role of CTLs in persistent viral infection: cytolytic gene expression in CD8+ lymphocytes distinguishes between individuals with a high or low proviral load of human T cell lymphotropic virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Modelling viral and immune system dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Quantification of the virus-host interaction in human T lymphotropic virus I infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Small variations in multiple parameters account for wide variations in HIV-1 set-points: a novel modelling approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Rapid production and clearance of HIV-1 and hepatitis C virus assessed by large volume plasma apheresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Decay characteristics of HIV-1-infected compartments during combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

Roles of target cells and virus-specific cellular immunity in primary simian immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ICB.7100050

21 January 2018

Identifiers

DOI

10.1038/SJ.ICB.7100050

1 reference

PubMed ID

17372609

Dimensions Publication ID

16 August 2017

0 references

1 reference

PubMed ID

17372609